CAS 1113-41-3|L-penicillamine
| Common Name | L-penicillamine | ||
|---|---|---|---|
| CAS Number | 1113-41-3 | Molecular Weight | 149.211 |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 251.8±35.0 °C at 760 mmHg |
| Molecular Formula | C5H11NO2S | Melting Point | 206ºC (dec.) |
| MSDS | ChineseUSA | Flash Point | 106.1±25.9 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | L-penicillamine |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 251.8±35.0 °C at 760 mmHg |
| Melting Point | 206ºC (dec.) |
| Molecular Formula | C5H11NO2S |
| Molecular Weight | 149.211 |
| Flash Point | 106.1±25.9 °C |
| Exact Mass | 149.051056 |
| PSA | 102.12000 |
| LogP | 0.93 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.528 |
| InChIKey | VVNCNSJFMMFHPL-GSVOUGTGSA-N |
| SMILES | CC(C)(S)C(N)C(=O)O |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 350 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
MUTATION DATA - TYPE OF TEST :
- Mutation in microorganisms
- TEST SYSTEM :
- Bacteria - Salmonella typhimurium
- DOSE/DURATION :
- 4 umol/plate
- REFERENCE :
- BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 34,3725,1985 *** REVIEWS *** TOXICOLOGY REVIEW PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 2,465,1979
- TYPE OF TEST :
- Mutation in microorganisms
- TEST SYSTEM :
- Bacteria - Salmonella typhimurium
- DOSE/DURATION :
- 4 umol/plate
- REFERENCE :
- BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 34,3725,1985 *** REVIEWS *** TOXICOLOGY REVIEW PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 2,465,1979
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | YV9445500 |
| HS Code | 2930909090 |
Customs
| HS Code | 2930909090 |
|---|---|
| Summary | 2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Articles10
More Articles| Circular muscle contraction in the mice rectum plays a key role in morphine-induced constipation. Neurogastroenterol. Motil. 26(10) , 1396-407, (2014) Although opioids induce intestinal muscle contraction and provoke constipation, the intestinal region(s) that contribute to the constipation have remained unclear. We report here a region-specific res... | |
| Inhibitors of bacterialN-succinyl-l,l-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity Bioorg. Med. Chem. Lett. 19 , 6350-2, (2009) A screen biased toward compounds containing zinc-binding groups (ZBG’s) delivered a number of micromolar inhibitors of DapE from Haemophilus influenzae, including l-captopril (IC 50 = 3.3 μM, K i = 1.... | |
| Acetyl- and butyryl-cholinesterase inhibitory activities of the edible brown alga Eisenia bicyclis. Arch. Pharm. Res. 38 , 1477-87, (2015) As part of our ongoing isolation of cholinesterase (ChE) inhibitors from natural marine sources, the bioactivity of the ethanolic extracts from 12 Korean seaweeds were screened for their inhibitory ac... |
Synonyms
| EINECS 214-203-9 |
| L(+)-Penicillamine |
| 2-Amino-3-mercapto-3-methylbutanoic acid |
| 3-mercapto-L-valine |
| 3-Sulfanyl-L-valine |
| L-β,β-Dimethylcysteine |
| L-Penicillamine |
| (R)-penicillamine |
| (±)-penicillamine |
| DL-Penicillamine |
| β, β-Dimethyl-DL-cysteine |
| β,β-Dimethyl-DL-cysteine |
| L-β-Mercaptovaline |
| (2R)-2-amino-3-mercapto-3-methyl-butyric acid |
| (2R)-2-amino-3-mercapto-3-methylbutanoic acid |
| 3,3-Dimethyl-DL-cysteine |
| 3-Sulfanylvaline |
| MFCD00064303 |
| Valine, 3-mercapto- |
| α-AMINO-β-METHYL-β-MERCAPTOBUTYRIC ACID |
| L-Valine, 3-mercapto- |
| H-Pen-OH |
